ABSCI CORP Operating Expenses
ABSCI CORP (ABSI) reported Operating Expenses of $34.48 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-11
- ABSCI CORP operating expenses for the quarter ending 2026-06-30 was $34.48M, a 7.78% increase year-over-year.
- ABSCI CORP operating expenses for the quarter ending 2026-03-31 was $31.06M, a 7.45% increase year-over-year.
- ABSCI CORP operating expenses for the quarter ending 2025-12-31 was $31.69M, a 4.11% increase year-over-year.
- ABSCI CORP operating expenses for the quarter ending 2025-09-30 was $30.53M, a 0.21% decline year-over-year.
- ABSCI CORP operating expenses for fiscal 2025 was $123.12M, a 8.55% increase from fiscal 2024.
- ABSCI CORP operating expenses for fiscal 2024 was $113.42M, a 6.44% decline from fiscal 2023.
- ABSCI CORP operating expenses for fiscal 2023 was $121.23M, a 7.77% increase from fiscal 2022.
- ABSCI CORP operating expenses for fiscal 2022 was $112.50M, a 40.59% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $34.48M 10-Q · filed 2026-08-11 | $65.54M 10-Q · filed 2026-08-11 | $97.23M derived: sum of 3 quarters · filed 2026-08-11 | $127.76M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $31.06M 10-Q · filed 2026-05-07 | $62.75M derived: sum of 2 quarters · filed 2026-05-07 | $93.28M derived: sum of 3 quarters · filed 2026-05-07 | $125.27M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $31.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $62.22M derived: sum of 2 quarters · filed 2026-03-24 | $94.21M derived: sum of 3 quarters · filed 2026-08-11 | $123.12M 10-K · filed 2026-03-24 |
| 2025-09-30 | $30.53M 10-Q · filed 2025-11-12 | $62.52M derived: sum of 2 quarters · filed 2026-08-11 | $91.43M 10-Q · filed 2025-11-12 | $121.86M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $31.99M 10-Q · filed 2026-08-11 | $60.89M 10-Q · filed 2026-08-11 | $91.33M derived: sum of 3 quarters · filed 2026-08-11 | $121.93M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $28.91M 10-Q · filed 2026-05-07 | $59.35M derived: sum of 2 quarters · filed 2026-05-07 | $89.94M derived: sum of 3 quarters · filed 2026-05-07 | $117.93M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $30.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $61.03M derived: sum of 2 quarters · filed 2026-03-24 | $89.03M derived: sum of 3 quarters · filed 2026-03-24 | $113.42M 10-K · filed 2026-03-24 |
| 2024-09-30 | $30.60M 10-Q · filed 2025-11-12 | $58.59M derived: sum of 2 quarters · filed 2025-11-12 | $82.98M 10-Q · filed 2025-11-12 | $108.06M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $27.99M 10-Q · filed 2025-08-12 | $52.39M 10-Q · filed 2025-08-12 | $77.46M derived: sum of 3 quarters · filed 2025-08-12 | $101.51M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $24.40M 10-Q · filed 2025-05-13 | $49.47M derived: sum of 2 quarters · filed 2025-05-13 | $73.52M derived: sum of 3 quarters · filed 2025-05-13 | $119.88M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $25.08M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $49.12M derived: sum of 2 quarters · filed 2025-03-18 | $95.48M derived: sum of 3 quarters · filed 2025-03-18 | $121.23M 10-K · filed 2025-03-18 |
| 2023-09-30 | $24.05M 10-Q · filed 2024-11-12 | $70.40M derived: sum of 2 quarters · filed 2024-11-12 | $96.16M 10-Q · filed 2024-11-12 | $118.81M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $46.35M 10-Q · filed 2024-08-14 | $72.11M 10-Q · filed 2024-08-14 | $94.76M derived: sum of 3 quarters · filed 2024-08-14 | $125.09M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $25.75M 10-Q · filed 2024-05-14 | $48.40M derived: sum of 2 quarters · filed 2024-05-14 | $78.74M derived: sum of 3 quarters · filed 2024-05-14 | $108.63M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $22.65M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $52.99M derived: sum of 2 quarters · filed 2024-03-21 | $82.88M derived: sum of 3 quarters · filed 2024-03-21 | $112.50M 10-K · filed 2024-03-21 |
| 2022-09-30 | $30.34M 10-Q · filed 2023-11-14 | $60.23M derived: sum of 2 quarters · filed 2023-11-14 | $89.85M 10-Q · filed 2023-11-14 | $117.56M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $29.89M 10-Q · filed 2023-08-14 | $59.51M 10-Q · filed 2023-08-14 | $87.22M derived: sum of 3 quarters · filed 2023-08-14 | $109.90M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $29.62M 10-Q · filed 2023-05-15 | $57.33M derived: sum of 2 quarters · filed 2023-05-15 | $80.01M derived: sum of 3 quarters · filed 2023-05-15 | $97.43M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $27.71M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $50.39M derived: sum of 2 quarters · filed 2023-03-30 | $67.81M derived: sum of 3 quarters · filed 2023-03-30 | $80.02M 10-K · filed 2023-03-30 |
| 2021-09-30 | $22.68M 10-Q · filed 2022-11-09 | $40.10M derived: sum of 2 quarters · filed 2022-11-09 | $52.31M 10-Q · filed 2022-11-09 | $59.67M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $17.42M 10-Q · filed 2022-08-11 | $29.63M 10-Q · filed 2022-08-11 | $36.99M derived: sum of 3 quarters · filed 2022-08-11 | $41.27M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $12.21M 10-Q · filed 2022-05-11 | $19.57M derived: sum of 2 quarters · filed 2022-05-11 | $23.85M derived: sum of 3 quarters · filed 2022-05-11 | $27.23M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $7.36M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $11.64M derived: sum of 2 quarters · filed 2022-03-22 | $15.02M derived: sum of 3 quarters · filed 2022-03-22 | $18.08M 10-K · filed 2022-03-22 |
| 2020-09-30 | $4.28M 10-Q · filed 2021-11-09 | $7.66M derived: sum of 2 quarters · filed 2021-11-09 | $10.72M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $3.38M 10-Q · filed 2021-09-07 | $6.44M 10-Q · filed 2021-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |